The story behind HAPPE Spine begins with Dr. Ryan Roeder and his twenty-year fascination with the material that makes up our bones.
After completing his PhD in material science and engineering in 1999, Dr. Roeder pursued his interest in biomedical work through post-doctoral research at the Indiana University School of Medicine in their Department of Orthopedic Surgery. It was here that he first became intrigued with bone as a unique, living, and adaptable material.
In 2001, Dr. Roeder joined the faculty of Notre Dame in the Department of Aerospace and Mechanical Engineering, where he continued his research in bone mechanics, fractures, osteoporosis and bone disease. This lead to an interest in orthopedic biomedical materials and how they interact, integrate, and replace bone in an implant.
Dr. Roeder began investigating the reinforcing of polymer constructs with hydroxyapatite clusters and ended up with a cancellous-structured polymer, which has exposed hydroxyapatite throughout the material. This process produced a very bone-friendly or body-friendly material that both wicks and integrates itself into the osteo structure.
Dr. Roeder began to develop the technology through the organization that he started, Spinesmith. But when they tried to gain interest within the industry, they ran into many different groups that didn’t feel that the scale-up was possible. Also, they didn’t have the right relationships to be able to create a viable commercial product out of this research technology.
In July 2018, Genesis Innovation Group announced the formation of HAPPE Spine, LLC. Genesis, along with cultivate(MD) Capital Funds made the investments into HAPPE Spine
This was an ideal opportunity for Genesis to step into. Because the Genesis team has decades of experience and knowledge across the industry, they’re able to leverage that with business partners, supply partners, vendors, and manufacturers to make this a viable product.
It’s really the vision that has come out of the Genesis team that allows this technology to be commercially brought to market.
Genesis has the ability to create those relationships to not only scale up the manufacturing but also generate the right marketed instrument solution and implant solution to bring this technology to the broader market.https://happeortho.com
About the Spinal Market
The Spinal implants and spinal devices market, by technology, includes spinal fusion and fixation, vertebral compression fracture treatment, and motion preservation/non-fusion technologies. On the basis of products, the global spinal implants and spinal devices market is divided into six major segments, namely, thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, vertebral compression fracture treatment devices, motion preservation/non-fusion treatment devices, and spine bone stimulators. Bases on the type of surgery, the global spinal implants and spinal devices market is divided into two segments, namely, open surgery and minimally invasive surgery. The spinal decompression devices market, by type of procedure, covers discectomy, laminotomy/laminectomy, foraminotomy/foraminectomy, facetectomy, and corpectomy procedures.The Spinal market is expected to reach USD 15.73 Billion by 2020, growing at a CAGR of 5.6% from 2015 to 2020. As of 2015, North America is estimated to hold the largest share of the global spinal implants and spinal devices market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2% from 2015 to 2020. A number of factors, including rising healthcare expenditure in developing nations owing to growing income levels, increasing government funding, presence of a large patient population, rising obesity cases, and growing awareness on the newly developed spine treatment techniques and devices are propelling the growth of the spinal implants and spinal devices market in the Asia-Pacific region. However, challenges associated with this market, such as scarcity of expertise and trained healthcare workers and lack of adequate patient awareness restricts the market growth in this region.Source: marketsandmarkets.com